Skip to main content

Table 1 (abstract P076). Clinical efficacy in Indian subset from REPROVE and RECLAIM studies

From: 39th International Symposium on Intensive Care and Emergency Medicine

Clinical Cure at TOC (%) in CE population Clinical Cure at TOC in cMITT(%)
CAZ‑AVI Meropenem CAZ‑AVI Meropenem
REPROVE study
 22/25 (88.0) 27/35 (77.1) 25/31 (80.6) 28/39 (71.8)
RECLAIM study
 45/46 (97.8) 42/44 (95.5) 50/56 (89.3) 50/59 (84.7)